BioCryst Pharmaceuticals
BCRX
BCRX
91 hedge funds and large institutions have $739M invested in BioCryst Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 102 → 91 (-11)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
Holders
91
Holding in Top 10
3
Calls
$5.83M
Puts
$4.63M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$6.33M | |
| 3 | +$5.57M | |
| 4 |
Axa
Paris,
France
|
+$3.96M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.12M |
Top Sellers
| 1 | -$5.13M | |
| 2 | -$3.65M | |
| 3 | -$3.14M | |
| 4 |
Morgan Stanley
New York
|
-$2.76M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.7M |